文献速递脑血管病

癌症相关卒中患者动脉血栓的凝血因子表达与组成

Coagulation Factor Expression and Composition of Arterial Thrombi in Cancer-Associated Stroke.
PubMed 文献 · Stroke · 2023-10-27

研究比较了癌症相关卒中患者与倾向评分匹配的无癌症卒中患者经血管内血栓切除术取出的脑血栓的组成与凝血因子表达。癌症组血栓中血小板、凝血酶和组织因子比例显著更高,X因子更低,且凝血酶与血小板在癌症组呈正相关。

要点

  • 癌症相关卒中患者脑血栓中血小板比例显著高于无癌症对照组。
  • 癌症组血栓中凝血酶和组织因子表达更高,X因子表达更低。
  • 癌症组凝血酶与血小板呈正相关,对照组无此相关性。

核心结论

  • 癌症相关卒中患者的脑血栓显示更高的血小板、凝血酶和组织因子比例,提示这些因素在癌症相关动脉血栓形成中起关键作用,并为预防癌症相关卒中提供治疗视角。

研究设计与样本

  • 研究纳入2014年9月至2020年6月期间接受血管内血栓切除术且获得脑血栓的卒中患者,分为癌症相关卒中组和无癌症对照组,按年龄和性别以1:1进行倾向评分匹配。
  • 对血栓进行免疫组化分析,比较两组血栓的组成和凝血因子表达。

主要发现

  • 在320例接受血管内血栓切除术并获得血栓的患者中,本研究纳入23例癌症患者和23例匹配对照。
  • 两组中位年龄均为65岁,男性均为12例(52.2%)。
  • 癌症组血小板组成显著高于对照组(中位数[四分位距],51.3%[28.0%-61.4%] vs 9.5%[4.8%-14.0%];P<0.001)。
  • 癌症组凝血酶(26.2%[16.2%-52.7%] vs 4.5%[1.3%-7.2%];P<0.001)和组织因子(0.60%[0.34%-2.06%] vs 0.37%[0.22%-0.60%];P=0.024)更高,X因子更低(1.25%[0.39%-3.60%] vs 2.33%[1.67%-4.48%];P=0.034)。
  • 癌症组凝血酶与血小板呈正相关(r=0.666;P=0.001),对照组无此相关性(r=-0.167;P=0.627)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Cancer is associated with an increased risk of stroke. Tumor cells activate platelets, induce a coagulation cascade, and generate thrombin. The composition of thrombi may reflect the mechanism of thrombosis, aiding the determination of the treatment strategy. Here, we investigated the composition and expression of coagulation factors in the thrombi of patients with cancer-associated stroke. METHODS: Patients with stroke who underwent endovascular thrombectomy between September 2014 and June 2020 and whose cerebral thrombi were obtained were divided into those with cancer-associated stroke (cancer group) and propensity score-matched patients without cancer (control group), using 1:1 matching based on age and sex. Immunohistochemistry was performed of the thrombi, and the composition and expression of coagulation factors were compared between groups. RESULTS: Among the 320 patients who underwent endovascular thrombectomy and who had thrombi obtained, this study included 23 patients with cancer and 23 matched controls. In both groups, the median age was 65 years, and 12 patients (52.2%) were men. Platelet composition was significantly higher in the cancer group than in the control group (median [interquartile range], 51.3% [28.0%-61.4%] versus 9.5% [4.8%-14.0%]; P<0.001). Among coagulation factors, thrombin (26.2% [16.2%-52.7%] versus 4.5% [1.3%-7.2%]; P<0.001) and tissue factors (0.60% [0.34%-2.06%] versus 0.37% [0.22%-0.60%]; P=0.024) were higher and factor X was lower (1.25% [0.39%-3.60%] versus 2.33% [1.67%-4.48%]; P=0.034) in the cancer group. There was a positive correlation between thrombin and platelets in the cancer group (r=0.666; P=0.001) but not in the control group (r=-0.167; P=0.627). CONCLUSIONS: Cerebral thrombi in patients with cancer-associated stroke showed higher proportions of platelets, thrombin, and tissue factors, suggesting their key roles in arterial thrombosis in cancer and providing a therapeutic perspective for preventing stroke in patients with cancer-associated stroke.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Yoo J, Kwon I, Kim S, et al. Coagulation Factor Expression and Composition of Arterial Thrombi in Cancer-Associated Stroke. Stroke. 2023. PMID: 37886852. doi:10.1161/STROKEAHA.123.044910

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。